GU Cancers 2023 | ASCO GU 2023: moving immunotherapy into the first-line setting for bladder cancer

Aristotelis Bamias, MD, National and Kapodistrian University of Athens, Athens, Greece, shares his highlights from the ASCO GU Cancers Symposium 2023, including two studies demonstrating encouraging results of moving immunotherapy to the first-line setting in non-muscle invasive bladder cancer (NMIBC). This interview took place at the ASCO GU Cancers Symposium 2023 in San Francisco, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.